https://www.selleckchem.com/pr....oducts/Decitabine.ht
tially between March and May 2020, suggesting a large number of patients have undiagnosed conditions. A rebound in future workload could be imminent as COVID-19 restrictions ease and patients with undiagnosed conditions or delayed diagnosis present to primary and secondary health-care services. Such services should prioritise the diagnosis and treatment of these patients to mitigate potential indirect harms to protect public health. National Institute of Health Research. National Institute of Health Research.Necroptosis induction in
Like
Comment
Share
